Functional Consequences of Mutations and Polymorphisms in Gonadotropin and Gonadotropin Receptor Genes

The Ovary: Second Edition

Volumn , Issue , 2004, Pages 55-78

  Huhtaniemi, Ilpo ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 27144484978     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012444562-8/50005-7     Document Type: Chapter

References (138)

1. Morgan F.J., Kammerman S., Canfield R.E. Chemistry of human chorionic gonadotropin. Handbook of Physiology, Vol. II, Female Reproductive System 1973, 311-322. Part 2, American Physiological Society Edition, Washington, D.C. R.O. Greep, E.A. Astwood (Eds.).
2. Sairam M.R., Parkoff H. Chemistry of pituitary gonadotropins. Handbook of Physiology, Vol. IV, The Pituitary Gland and Its Neuroendocrine Control 1973, 111-131. Part 2, American Physiological Society Edition, Washington, D.C. R.O. Greep, E.A. Astwood (Eds.).
3. Fiete D., Srivastava V., Hindsgaul O., Baenziger J.U. A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc beta 1,4GlcNAc beta 1,2Man alpha that mediates rapid clearance of lutropin. Cell 1991, 67:1103-1110.
4. Lapthorn A.J., Harris D.C., Littlejohn A., Lustbader J.W., Canfield R.E., Machin K.J., Morgan F.J., Isaacs N.W. Crystal structure of human chorionic gonadotropin. Nature 1994, 369:455-461.
5. Fox K.M., Dias J.A., Van Roey P. Three-dimensional structure of human follicle-stimulating hormone. Mol. Endocrinol. 2001, 15:378-389.
6. Bousfield G.R., Perry W.M., Ward D.N. Gonadotropins. Chemistry and biosynthesis. The Physiology of Reproduction 1994, 1749-1792. Raven Press, New York. 2d ed. E. Knobil, J.D. Neill (Eds.).
7. Bo M., Boime I. Identification of the transcriptionally active genes of the chorionic gonadotropin β gene cluster in vitro. J. Biol. Chem. 1992, 267:3179-3184.
8. Dias J.A. Is there any physiological role for gonadotropin oligosaccharide heterogeneity in humans? II. A biochemical point of view. Hum. Reprod. 2001, 16:825-830.
9. Ulloa-Aguirre A., Maldonado A., Damian-Matsumura P., Timossi C. Endocrine regulation of gonadotropin glycosylation. Arch. Med. Res. 2001, 32:520-532.
10. Dias J., Van Roey P. Structural biology of human follitropin and its receptor. Arch. Med. Res. 2001, 32:510-519.
11. Chen H.C., Shimohigashi Y., Dufau M.L., Catt K.J. Characterization and biological properties of chemically deglycosylated human chorionic gonadotropin. Role of carbohydrate moieties in adenylate cyclase activation. J. Biol. Chem. 1982, 257:1446-14452.
12. Garcia-Campayo V., Boime I. Novel recombinant gonadotropins. Trends Endocrinol. Metab. 2001, 12:72-77.
13. Lustbader J.W., Lobel L., Wu H., Elliott M.M. Structural and molecular studies of human chorionic gonadotropin and its receptor. Rec. Prog. Hormone Res. 1998, 53:395-424.
14. Segaloff D.L., Ascoli M. The lutropin/choriogonadotropin receptor ... 4 years later. Endocr. Rev. 1993, 14:324-347.
15. Ascoli M., Fanelli F., Segaloff D.L. The lutropin/choriogonadotropin receptor: A 2002 perspective. Endocr. Rev. 2002, 23:141-174.
16. Simoni M., Gromoll J., Nieschlag E. The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocr. Rev. 1997, 18:739-773.
17. Themmen A.P.N., Huhtaniemi I.T. Mutations of gonadotropins and gonadotropin receptors: Elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr. Rev. 2000, 21:551-583.
18. Atger M., Misrahi M., Sar S., Le Flem L., Dessen P., Milgrom E. Structure of the human luteinizing hormone-choriogonadotropin receptor gene: Unusual promoter and 5' non-coding regions. Mol. Cell. Endocrinol. 1995, 111:113-123.
19. Tsai-Morris C.H., Geng Y., Buczko E., Dufau M.L. A novel human luteinizing hormone receptor gene. J. Clin. Endocrinol. Metab. 1998, 83:288-291.
20. Hämäläinen T., Poutanen M., Huhtaniemi I. Promoter function of different lengths of the murine luteinizing hormone receptor gene 5'-flanking region in transfected gonadal cells and in transgenic mice. Endocrinology 2001, 142:2427-2434.
21. Zhang F.-P., Hämäläinen T., Kaipia A., Pakarinen P., Huhtaniemi I. Ontogeny of luteinizing hormone receptor gene expression in the rat testis. Endocrinology 1994, 134:2206-2213.
22. Sokka T.A., Hämäläinen T.M., Kaipia A., Warren D.W., Huhtaniemi I.T. Development of luteinizing hormone action in the perinatal rat ovary. Biol. Reprod. 1996, 55:663-670.
23. Davis D.P., Rozell T.G., Liu X., Segaloff D.L. The six N-linked carbohydrates of the lutropin/choriogonadotropin receptor are not absolutely required for correct folding, cell surface expression, hormone binding, or signal transduction. Mol. Endocrinol. 1997, 11:550-562.
24. Tapanainen J.S., Bo M., Dunkel L., Billig H., Perlas E., Boime I., Hsueh A.J.W. Deglycosylation of the human luteinizing hormone receptor does not affect ligand binding and signal transduction. Endocrine 1993, 1:219-225.
25. Bhowmick N., Huang J., Puett D., Isaacs N.W., Lapthorn A.J. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Mol. Endocrinol. 1996, 10:1147-1159.
26. Song Y.S., Ji I., Beauchamp J., Isaacs N.W., Ji T.H. Hormone interactions to Leu-rich repeats in the gonadotropin receptors. I. Analysis of Leu-rich repeats of human luteinizing hormone/chorionic gonadotropin receptor and follicle-stimulating hormone receptor. J. Biol. Chem. 2001, 276:3426-3435.
27. Kajava A.V. Structural diversity of leucine-rich repeat proteins. J. Mol. Biol. 1998, 277:519-527.
28. Kobe B., Deisenhofer J. The leucine-rich repeat: A versatile binding motif. Trends Biochem. Sci. 1994, 19:415-421.
29. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., Miyano M. Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000, 289:739-745.
30. Angelova K., Fanelli F., Puett D. A model for constitutive lutropin receptor activation based on molecular simulation and engineered mutations in transmembrane helices 6 and 7. J. Biol. Chem. 2002, 277:32202-32213.
31. Abell A.N., Segaloff D.L. Evidence for the direct involvement of transmembrane region 6 of the lutropin/choriogonadotropin receptor in activating Gs. J. Biol. Chem. 1997, 272:14586-14591.
32. Kudo M., Osuga Y., Kobilka B.K., Hsueh A.J. Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J. Biol. Chem. 1996, 271:22470-22478.
33. Kawate N., Peegel H., Menon K.M. Role of palmitoylation of conserved cysteine residues of luteinizing hormone/human choriogonadotropin receptors in receptor down-regulation. Mol. Cell. Endocrinol. 1997, 127:211-219.
34. Hipkin R.W., Sanchez-Yague J., Ascoli M. Agonist-induced phosphorylation of the luteinizing hormone/chorionic gonadotropin receptor expressed in a stably transfected cell line. Mol. Endocrinol. 1993, 7:823-832.
35. Gudermann T., Schoneberg T., Schultz G. Functional and structural complexity of signal transduction via G protein-coupled receptors. Annu. Rev. Neurosci. 1997, 20:399-427.
36. Kuhn B., Gudermann T. The luteinizing hormone receptor activates phospholipase C via preferential coupling to Gi2. Biochemistry 1999, 38:12490-12498.
37. Rajagopalan-Gupta R.M., Lamm M.L., Mukherjee S., Rasenick M.M., Hunzicker-Dunn M. Luteinizing hormone/choriogonadotropin receptor-mediated activation of heterotrimeric guanine nucleotide binding proteins in ovarian follicular membranes. Endocrinology 1998, 139:4547-4555.
38. Gudermann T., Birnbaumer M., Birnbaumer L. Evidence for dual coupling of the murine luteinizing hormone receptor to adenylyl cyclase and phosphoinositide breakdown and Ca2+ mobilization. Studies with the cloned murine luteinizing hormone receptor expressed in L cells. J. Biol. Chem. 1992, 267:4479-4488.
39. Hirakawa T., Galet C., Ascoli M. MA-10 cells transfected with the human lutropin/choriogonadotropin receptor (hLHR): A novel experimental paradigm to study the functional properties of the hLHR. Endocrinology 2002, 143:1026-1035.
40. Tilly J.L., LaPolt P.S., Hsueh A.J. Hormonal regulation of follicle-stimulating hormone receptor messenger ribonucleic acid levels in cultured rat granulosa cells. Endocrinology 1992, 130:1296-1302.
41. Davis D., Liu X., Segaloff D.L. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol. Endocrinol. 1995, 9:159-170.
42. Braun T., Schofield P.R., Sprengel R. Aminoterminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J. 1991, 10:1885-1890.
43. Sassone-Corsi P. CREM: A master-switch governing male germ cells differentiation and apoptosis. Semin. Cell. Dev. Biol. 1998, 9:475-482.
44. Don J., Stelzer G. The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis. Mol. Cell. Endocrinol. 2002, 187:115-124.
45. Quintana J., Hipkin R.W., Sanchez-Yague J., Ascoli M. Follitropin (FSH) and a phorbol ester stimulate the phosphorylation of the FSH receptor in intact cells. J. Biol. Chem. 1994, 269:8772-8779.
46. Monaco L., Adamo S., Conti M. Follicle-stimulating hormone modulation of phosphoinositide turnover in the immature rat Sertoli cell in culture. Endocrinology 1988, 123:2032-2039.
47. Grasso P., Reichert L.E. Induction of calcium transport into cultured rat Sertoli cells and liposomes by follicle-stimulating hormone. Rec. Prog. Hormone Res. 1993, 48:517-521.
48. Nishimura R., Shin J., Ji I., Middaugh C.R., Kruggel W., Lewis R.V., Ji T.H. A single amino acid substitution in an ectopic α-subunit of a human carcinoma choriogonadotropin. J. Biol. Chem. 1986, 261:10475-10477.
49. Kendall S.K., Samuelson L.C., Saunders T.L., Wood R.I., Camper S.A. Targeted disruption of the pituitary glycoprotein hormone α-subunit produces hypogonadal and hypothyroid mice. Genes Dev. 1995, 9:2007-2019.
50. Weiss J., Axelrod L., Whitcomb R.W., Crowley W.F., Jameson J.L. Hypogonadism caused by a single amino acid substitution in the beta-subunit of luteinizing hormone. N. Engl. J. Med. 1992, 326:179-183.
51. Beitins I.Z., Axelrod L., Ostrea T., Little R., Badger T.M. Hypogonadism in a male with an immunologically active, biologically inactive luteinizing hormone: Characterization of the abnormal hormone. J. Clin. Endocrinol. Metab. 1981, 52:1143-1149.
52. Achermann J.C., Weiss J., Lee E.J., Jameson J.L. Inherited disorders of the gonadotropin hormones. Mol. Cell. Endocrinol. 2001, 179:89-96.
53. Toledo S.P., Brunner H.G., Kraaij R., Post M., Dahia P.L., Hayashida C.Y., Kremer H., Themmen A.P. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J. Clin. Endocrinol. Metab. 1996, 81:3850-3854.
54. Gaillard, R., and Beckers, A., personal communication.
55. Lamminen T., Huhtaniemi I. A common genetic variant of luteinizing hormone: Relation to normal and aberrant pituitary-gonadal function. Eur. J. Pharmacol. 2001, 414:1-7.
56. Pettersson K., Ding Y.Q., Huhtaniemi I. An immunologically anomalous luteinizing hormone variant in a healthy woman. J. Clin. Endocrinol. Metab. 1992, 74:164-171.
57. Furui K., Suganuma N., Tsukahara S., Asada Y., Kikkawa F., Tanaka M., Ozawa T., Tomoda Y. Identification of two point mutations in the gene coding luteinizing hormone (LH) beta-subunit, associated with immunologically anomalous LH variants. J. Clin. Endocrinol. Metab. 1994, 78:107-113.
58. Okuda K., Yamada T., Imoto H., Komatsubara H., Sugimoto O. Antigenic alteration of an anomalous human luteinizing hormone caused by two chorionic gonadotropin-type amino-acid substitutions. Biochem. Biophys. Res. Commun. 1994, 200:584-590.
59. Pettersson K., Mäkelä M.M., Dahlén P., Lamminen T., Huoponen K., Huhtaniemi I. Genetic polymorphism found in the LHβ gene of an immunologically anomalous variant of human luteinizing hormone. Eur. J. Endocrinol. 1994, 130(Suppl 2):65.
60. Nilsson C., Jiang M., Pettersson K., Iitiä A., Mäkelä M., Simonsen H., Easteal S., Herrera R.J., Huhtaniemi I. Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays. Clin. Endocrinol. (Oxf.) 1998, 49:369-376.
61. Suganuma N., Furui K., Furuhashi M., Asada Y., Kikkawa F., Tomoda Y. Screening of the mutations in luteinizing hormone beta-subunit in patients with menstrual disorders. Fertil. Steril. 1995, 63:989-995.
62. Takahashi K., Kurioka H., Ozaki T., Kanasaki H., Kohsaka M., Miyazaki K., Karino K. Increased prevalence of luteinizing hormone beta-subunit variant in Japanese infertility patients. Hum. Reprod. 1998, 13:3338-3344.
63. Takahashi K., Ozaki T., Okada M., Kurioka H., Kanasaki H., Miyazaki K. Increased prevalence of luteinizing hormone beta-subunit variant in patients with premature ovarian failure. Fertil. Steril. 1999, 71:96-101.
64. Cramer D.W., Petterson K.S., Barbieri R.L., Huhtaniemi I.T. Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone. Hum. Reprod. 2000, 15:2103-2107.
65. Tulppala M., Huhtaniemi I., Ylikorkala O. Genetic variant of luteinizing hormone in women with a history of recurrent miscarriage. Hum. Reprod. 1998, 13:2699-2702.
66. Rajkhowa M., Talbot J.A., Jones P.W., Pettersson K., Haavisto A.M., Huhtaniemi I., Clayton R.N. Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 1995, 43:297-303.
67. Hill M., Huhtaniemi I.T., Hampl R., Starka L. Genetic variant of luteinizing hormone: Impact on gonadal steroid sex hormones in women. Physiol. Res. 2001, 50:583-587.
68. Tapanainen J.S., Koivunen R., Fauser B.C., Taylor A.E., Clayton R.N., Rajkhowa M., White D., Franks S., Anttila L., Pettersson K.S., Huhtaniemi I.T. A new contributing factor to polycystic ovary syndrome: The genetic variant of luteinizing hormone. J. Clin. Endocrinol. Metab. 1999, 84:1711-1715.
69. Suganuma N., Furui K., Kikkawa F., Tomoda Y., Furuhashi M. Effects of the mutations (Trp8 → Arg and Ile15 → Thr) in human luteinizing hormone (LH) beta-subunit on LH bioactivity in vitro and in vivo. Endocrinology 1996, 137:831-838.
70. Suzuki S., Furuhashi M., Suganuma N. Additional N-glycosylation at Asn(13) rescues the human LHbeta-subunit from disulfide-linked aggregation. Mol. Cell. Endocrinol. 2000, 160:157-163.
71. Haavisto A.-M., Pettersson K., Bergendahl M., Virkamäki A., Huhtaniemi I. Occurrence and biological properties of a common genetic variant of luteinizing hormone. J. Clin. Endocrinol. Metab. 1995, 80:1257-1263.
72. Manna P.R., Joshi L., Reinhold V.N., Aubert M.L., Suganuma N., Pettersson K., Huhtaniemi I.T. Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone. Hum. Mol. Genet. 2002, 11:301-315.
73. Jiang M., Pakarinen P., Zhang F.-P., El-Hefnawy T., Koskimies P., Pettersson K., Huhtaniemi I. A common polymorphic allele of the human luteinizing hormone beta-subunit gene: Additional mutations and differential function of the promoter sequence. Hum. Mol. Genet. 1999, 8:2037-2046.
74. Roy A.C., Liao W.X., Chen Y., Arulkumaran S., Ratnam S.S. Identification of seven novel mutations in LH beta-subunit gene by SSCP. Mol. Cell. Biochem. 1996, 165:151-153.
75. Ramanujam L.N., Liao W.X., Roy A.C., Loganath A., Goh H.H., Ng S.C. Association of molecular variants of luteinizing hormone with menstrual disorders. Clin. Endocrinol. (Oxf.) 1999, 51:243-246.
76. 102Ser mutation in Asian populations. Mol. Hum. Reprod. 2002, 10:887-892.
77. Jiang M., Lamminen T., Pakarinen P., Hellman J., Manna P., Herrera R.J., Huhtaniemi I. A novel Ala(-3)Thr mutation in the signal peptide of human luteinizing hormone beta-subunit: Potentiation of the inositol phosphate signaling pathway and attenuation of the adenylate cyclase pathway by recombinant variant hormone. Mol. Hum. Reprod. 2002, 8:201-212.
78. Layman L.C., Edwards J.L., Osborne W.E., Peak D.B., Gallup D.G., Tho S.P., Reindollar R.H., Roach D.J., McDonough P.G., Lanclos K.D. Human chorionic gonadotropin-beta gene sequences in women with disorders of HCG production. Mol. Hum. Reprod. 1997, 3:315-320.
79. Miller-Lindholm A.K., Bedows E., Bartels C.F., Ramey J., Maclin V., Ruddon R.W. A naturally occurring genetic variant in the human chorionic gonadotropin-beta gene 5 is assembly inefficient. Endocrinology 1999, 140:3496-3506.
80. Matthews C.H., Borgato S., Beck-Peccoz P., Adams M., Tone Y., Gambino G., Casagrande S., Tedeschini G., Benedetti A., Chatterjee V.K. Primary amenorrhoea and infertility caused by a mutation in the beta-subunit of follicle-stimulating hormone. Nat. Genet. 1993, 5:83-86.
81. Layman L.C., Lee E.J., Peak D.B., Namnoum A.B., Vu K.V., van Lingen B.L., Gray M.R., McDonough P.G., Reindollar R.H., Jameson J.L. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N. Engl. J. Med. 1997, 337:607-611.
82. Matthews C., Chatterjee V.K. Isolated deficiency of follicle-stimulating hormone re-revisited. N. Engl. J. Med. 1997, 337:642.
83. Layman L.C., Porto A.L.A., Xie J., da Motta L.A., da Motta L.D., Weiser W., Sluss P.M. FSHβ gene mutations in a female with a partial breast development and a male sibling with normal puberty and azoospermia. J. Clin. Endocrinol. Metab. 2002, 87:3702-3707.
84. Lindstedt G., Nyström E., Matthews C., Ernest I., Janson P.O., Chatterjee K. Follitropin (FSH) deficiency in an infertile male due to FSHbeta gene mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clin. Chem. Lab. Med. 1998, 36:663-665.
85. Barnes R.B., Namnoum A.B., Rosenfield R.L., Layman L.C. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: Clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum. Reprod. 2002, 17:88-91.
86. Aittomäki K., Herva R., Stenman U.-H., Juntunen K., Ylöstalo P., Hovatta O., de la Chapelle A. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J. Clin. Endocrinol. Metab. 1996, 81:3722-3726.
87. Vaskivuo T.E., Aittomäki K., Anttonen M., Ruokonen A., Herva R., Osawa Y., Heikinheimo M., Huhtaniemi I., Tapanainen J.S. Effects of follicle-stimulating hormone (FSH) and human chorionic gonadotropin in individuals with inactivating mutation of the FSH receptor. Fertil. Steril. 2002, 78:108-113.
88. Abel M.H., Huhtaniemi I., Pakarinen P., Kumar R., Charlton H.M. Age related uterine and ovarian hypertrophy in follicle stimulating hormone (FSH) receptor knockout and FSHß subunit knockout mice. Reproduction 2003, in press.
89. Baker P.J., Pakarinen P., Huhtaniemi I.T., Abel M.H., Charlton H.M., Kumar T.R., O'Shaughnessy P.J. Failure of normal Leydig cell development in FSH receptor-deficient mice, but not FSHß deficient mice: Role for constitutive FSH receptor activity. Endocrinology 2003, 144:138-145.
90. Phillip M., Arbelle J.E., Segev Y., Parvari R. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N. Engl. J. Med. 1998, 338:1729-1732.
91. Tapanainen J.S., Aittomäki K., Min J., Vaskivuo T., Huhtaniemi I.T. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat. Genet. 1997, 15:205-206.
92. Kumar T.R., Wang Y., Lu N., Matzuk M.M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet. 1997, 15:201-204.
93. Dierich A., Sairam M.R., Monaco L., Fimia G.M., Gansmuller A., LeMeur M., Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo: Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc. Natl. Acad. Sci. USA 1998, 95:13612-13617.
94. Abel M.H., Wootton A.N., Wilkins V., Huhtaniemi I., Knight P.G., Charlton H.M. The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 2000, 141:1795-1803.
95. Huhtaniemi I. The role of mutations affecting gonadotropin secretion and action in disorders of pubertal development. Best Pract. and Res.; Clin. Endocrinol. & Metab. 2002, 16:123-138.
96. Kremer H., Mariman E., Otten B.J., Moll G.W., Stoelinga G.B., Wit J.M., Jansen M., Drop S.L., Faas B., Ropers H.H., Themmen A.P.N., Brunner H.G. Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Hum. Mol. Genet. 1993, 2:1779-1783.
97. Shenker A., Laue L., Kosugi S., Merendino J.J., Minegishi T., Cutler G.B. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993, 365:652-654.
98. Liu G., Duranteau L., Carel J.C., Monroe J., Doyle D.A., Shenker A. Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N. Engl. J. Med. 1999, 341:1731-1736.
99. Canto P., Söderlund D., Ramón G., Nishimura E., Méndez J.P. Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors. Am. J. Med. Genet. 2002, 108:148-152.
100. Richter-Unruh A., Wessels H.T., Menken U., Bergmann M., Schmittmann-Ohters K., Schaper J., Tappeser S., Hauffa B.P. Male LH-independent sexual precocity in a 3.5-year-old boy caused by somatic activating mutation of the LH receptor in a Leydig cell tumor. J. Clin. Endocrinol. Metab. 2002, 87:1052-1056.
101. Leschek E.W., Chan W.Y., Diamond D.A., Kaefer M., Jones J., Barner K.M., Cutler G.B. Nodular Leydig cell hyperplasia in a boy with male-limited precocious puberty. J. Pediatr. 2001, 138:949-951.
102. Martin M.M., Wu S.-M., Martin A.L.A., Rennert O.M., Chan W.-Y. Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor. Eur. J. Endocrinol. 1998, 139:101-106.
103. Paschke R., Ludgate M. The thyrotropin receptor in thyroid diseases. N. Engl. J. Med. 1997, 337:1675-1681.
104. Parma J., Duprez L., Van Sande J., Hermans J., Rocmans P., Van Vliet G., Costagliola S., Rodien P., Dumont J.E., Vassart G. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsa genes as a cause of toxic thyroid adenomas. J. Clin. Endocrinol. Metab. 1997, 82:2695-2701.
105. Russo D., Tumino S., Arturi F., Vigneri P., Grasso G., Pontecorvi A., Filetti S., Belfiore A. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J. Clin. Endocrinol. Metab. 1997, 82:735-738.
106. Fanelli F. Theoretical study on mutation-induced activation of the luteinizing hormone receptor. J. Mol. Biol. 2000, 296:1333-1351.
107. Shenker A. Activating mutations of the lutropin choriogonadotropin receptor in precocious puberty. Receptors Channels 2002, 8:3-18.
108. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 2000, 21:90-113.
109. Nef S., Parada L.F. Hormones in male sexual development. Genes Dev. 2000, 14:3075-3086.
110. Kremer H., Kraaij R., Toledo S.P., Post M., Fridman J.B., Hayashida C.Y., van Reen M., Milgrom E., Ropers H.H., Mariman E., Themmen A.P.N., Brunner H.G. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat. Genet. 1995, 9:160-164.
111. Latronico A.C., Anasti J., Arnhold I.J., Rapaport R., Mendonca B.B., Bloise W., Castro M., Tsigos C., Chrousos G.P. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone receptors gene. N. Engl. J. Med. 1996, 331:507-512.
112. Toledo S.P., Brunner H.G., Kraaij R., Post M., Dahia P.L., Hayashida C.Y., Kremer H., Themmen A.P. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female. J. Clin. Endocrinol. Metab. 1996, 81:3850-3854.
113. Laue L., Wu S.M., Kudo M., Hsueh A.J., Cutler G.B., Griffin J.E., Wilson J.D., Brain C., Berry A.C., Grant D.B., Chan W.Y. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum. Mol. Genet. 1995, 4:1429-1433.
114. Martens J.W.M., Lumbroso S., Verhoef-Post M., Georget V., Richter-Unruh A., Szarras-Czapnik M., Romer T.E., Brunner H.G., Themmen A.P.N., Sultan C. Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: Abnormal processing causes signaling deficiency. J. Clin. Endocrinol. Metab. 2002, 87:2506-2513.
115. Martens J.W., Verhoef-Post M., Abelin N., Ezabella M., Toledo S.P., Brunner H.G., Themmen A.P. A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: Correlation between receptor activity and phenotype. Mol. Endocrinol. 1998, 12:775-784.
116. Gromoll J., Eiholzer U., Nieschlag E., Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: Differential action of human chorionic gonadotropin and LH. J. Clin. Endocrinol. Metab. 2000, 85:2281-2286.
117. Zhang F.-P., Poutanen M., Wilbertz J., Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol. Endocrinol. 2001, 15:172-183.
118. Lei Z.M., Mishra S., Zou W., Xu B., Foltz M., Li X., Rao C.V. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Mol. Endocrinol. 2001, 15:184-200.
119. Mongan N.P., Hughes I.A., Lim H.N. Evidence that luteinising hormone receptor polymorphisms may contribute to male undermasculinisation. Eur. J. Endocrinol. 2002, 147:103-107.
120. Gromoll J., Simoni M., Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J. Clin. Endocrinol. Metab. 1996, 81:1367-1370.
121. Haywood M., Tymchenko N., Spaliviero J., Koch A., Jimenez M., Gromoll J., Simoni M., Nordhoff V., Handelsman D.J., Allan C.M. An activated human follicle-stimulating hormone (FSH) receptor stimulates FSH-like activity in gonadotropin-deficient transgenic mice. Mol. Endocrinol. 2002, 16:2582-2591.
122. Tao Y.X., Abell A.N., Liu X., Nakamura K., Segaloff D.L. Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III. Mol. Endocrinol. 2000, 14:1272-1282.
123. Gicalglia L.R., da Fonte Kohek M.B., Carvalho F.M., Villares Fragaso M.C.B., Mendonca B.B., Latronico A.C. No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors. Fertil. Steril. 2000, 64:992-995.
124. Takakura K., Takebayashi K., Wang H.-Q., Kimura F., Kasahara K., Noda Y. Follicle-stimulating hormone receptor gene mutations are rare in Japanese women with premature ovarian failure and polycystic ovary syndrome. Fertil. Steril. 2001, 75:207-209.
125. Tong Y., Liao W.X., Roy A.C., Ng S.C. Absence of mutations in the coding regions of follicle-stimulating hormone receptor gene in Singapore Chinese women with premature ovary failure and polycystic ovary syndrome. Horm. Metab. Res. 2001, 33:221-226.
126. de la Chesnaye E., Canto P., Ulloa-Aguirre A., Mendez J.P. No evidence of mutations in the follicle-stimulating hormone receptor gene in Mexican women with 46,XX pure gonadal dysgenesis. Am. J. Med. Genet. 2001, 98:129-135.
127. Montgomery G.W., Duffy D.L., Hall J., Kudo M., Martin N.G., Hsueh A.J. Mutations in the follicle-stimulating hormone receptor and familial dizygotic twinning. Lancet 2001, 357:773-774.
128. Aittomäki K., Dieguez Lucena J.L., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., Kaskikari R., Sankila E.-M., Lehväslaiho H., Reyes Engel A., Nieschlag E., Huhtaniemi I., de la Chapelle A. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995, 82:959-968.
129. Rannikko A., Pakarinen P., Manna P.R., Beau I., Misrahi M., Aittomäki K., Huhtaniemi I. Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation. Mol. Hum. Reprod. 2002, 8:311-317.
130. Beau I., Touraine P., Meduri G., Gougeon A., Desroches A., Matuchansky C., Milgrom E., Kuttenn F., Misrahi M. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J. Clin. Invest. 1998, 102:1352-1359.
131. Touraine P., Beau I., Gougeon A., Meduri G., Desroches A., Pichard C., Detoeuf M., Paniel B., Prieur M., Zorn J.R., Milgrom E., Kuttenn F., Misrahi M. New natural inactivating mutations of the follicle-stimulating hormone receptor: Correlations between receptor function and phenotype. Mol. Endocrinol. 1999, 13:1844-1854.
132. Gromoll J., Simoni M., Nordhoff V., Behre H.M., De Geyter C., Nieschlag E. Functional and clinical consequences of mutations in the FSH receptor. Mol. Cell. Endocrinol. 1996, 125:177-182.
133. Doherty E., Pakarinen P., Tiitinen A., Kiilavuori A., Huhtaniemi I., Forrest S., Aittomaki K. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J. Clin. Endocrinol. Metab. 2002, 87:1151-1155.
134. Allen L.A., Achermann J.C., Pakarinen P., Kotlar T.J., Huhtaniemi I.T., Jameson L.J., Cheetham T.D., Ball S.G. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotropic hypogonadism: Clinical and molecular characteristics. Hum. Reprod. 2003, in press.
135. Gromoll J., Schulz A., Borta H., Gudermann T., Teerds K.J., Greschniok A., Nieschlag E., Seif F.J. Homozygous mutation within the conserved Ala-Phe-Asn-Glu-Thr motif of exon 7 of the LH receptor causes male pseudohermaphroditism. Eur. J. Endocrinol. 2002, 147:597-608.
136. Perez Mayorga M., Gromoll J., Behre H.M., Gassner C., Nieschlag E., Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J. Clin. Endocrinol. Metab. 2000, 85:3365-3369.
137. Laven J.S., Mulders A.G., Simoni M., Gromoll J., Fauser B.C. Follicle-stimulating hormone (FSH) receptor genotype in normogonadotropic anovulatory infertile (WHO II) patients and normo-ovulatory controls. The Endocrine Society, Annual Meeting 2002, Abstract no. OR60-1.
138. Asantiani K., Gromoll J., Eckardstein S.V., Zitzmann M., Nieschlag E., Simoni M. Distribution and function of FSH receptor genetic variants in normal men. Andrologia 2002, 34:172-176.